Published 3 November 2021

The Gaps Between HCP Demand and Pharma Supply of Medical Information

How Pharma-HCP engagement should evolve as we emerge from the pandemic

MIND THE GAP!

8.6

The average score out of 10 given to the report by readers

1k+

people in the pharma industry accessed the report in 1 month

0%

of HCPs expect their demand for virtual scientific meetings to remain higher post-pandemic

0%

of HCPs consider independent websites critical or very important for disease awareness

0%

of pharma expect to primarily create their own disease awareness in 2022

Since the onset of the COVID pandemic, life science companies have ‘acted’ quickly to address the evolving needs of healthcare professionals (HCPs), knowing that customer centricity is key to meaningful engagement. However, our multi-stakeholder research, which examines the situation 18 months on, indicates that pharmaceutical companies are missing the mark on HCP engagement, with a clear customer-centric paradox.

The 65-page report provides insight into HCP demands for medical information, industry supply, progress made, lessons learnt, the gaps that now exist, and the challenges yet to overcome. It will help you to identify where your organisation is falling short and validate or steer your strategic and tactical plans for 2022 related to:

  • Medical content
  • Evolving channels
  • Scientific meetings
  • Websites
  • Digital capability and maturity
  • Resource, roles and collaboration
  • Beyond the pandemic

DOWNLOAD THE REPORT FOR FREE

By submitting my details, I agree to EPG Health processing my data according to its privacy and cookies policy and consent to EPG Health using them to contact me occasionally about relevant research, whitepapers, services and events. I understand that I will have the option to opt-out of communications at any time.